Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus by Bouchemal, K et al.
  
 
 
This is an author version of the contribution published on: 
Questa è la versione dell’autore dell’opera: 
Antimicrob Agents Chemother. 2015 Apr;59(4):2215-22. doi: 10.1128/AAC.03503-14. 
The definitive version is available at: 
La versione definitiva è disponibile alla URL: 
http://www.asm.org/ 
 
  
 
 
Thermosensitive and Mucoadhesive Pluronic-Hydroxypropylmethylcellulose Hydrogel 
Containing the Mini-CD4 M48U1 Is a Promising Efficient Barrier against HIV Diffusion 
through Macaque Cervicovaginal Mucus 
Kawthar Bouchemal
a
,  Armelle Aka-Any-Grah
a
,
b
,  Nathalie Dereuddre-Bosquet
c
, Loïc Martin
d
, Vanessa Lievin-
Le-Moal
e
, Roger Le Grand
c
,  Valérie Nicolas
f
,  Davide Gibellini
g
,  David Lembo
h
,  Christian Poüs
i
,  Armand 
Koffi
b
 and  Gilles Ponchel
a
 
a
Université Paris-Sud, Institut Galien Paris Sud, UMR CNRS 8612, Faculté de Pharmacie, Châtenay-Malabry, 
France 
b
Université Félix Houphouet Boigny-Cocody, UFR des Sciences Pharmaceutiques et Biologiques, Laboratoire de 
Pharmacie Galénique, Biopharmacie et Législation, Abidjan, Côte d'Ivoire 
c
CEA, iMETI, Division of Immuno-Virology, Fontenay-aux Roses, France 
d
CEA, iBiTecS, Service d'Ingénierie Moléculaire des Protéines (SIMOPRO), Gif sur Yvette, France 
e
Antiparasitic Chemotherapy, UMR CNRS 8076, Faculté de Pharmacie, Châtenay-Malabry, France 
f
Université Paris-Sud, IFR 141, Faculté de Pharmacie, Châtenay-Malabry, France 
g
Department of Pathology and Diagnostic, Microbiology and Virology Unit, University of Verona, Verona, Italy 
h
University of Turin, Department of Clinical and Biological Sciences, S. Luigi Gonzaga Hospital Regione 
Gonzole, Orbassano, Turin, Italy 
i
Biochimie et Biologie Cellulaire-JE2493, Université Paris-Sud, IFR 141, Faculté de Pharmacie, Châtenay-
Malabry, France 
 
ABSTRACT 
To be efficient, vaginal microbicide hydrogels should form a barrier against viral infections and prevent virus spreading 
through mucus. Multiple particle tracking was used to quantify the mobility of 170-nm fluorescently labeled COOH-
modified polystyrene particles (COOH-PS) into thermosensitive hydrogels composed of amphiphilic triblock 
copolymers with block compositions EOn-POm-EOn (where EO refers to ethylene oxide and PO to propylene oxide) 
containing mucoadhesive hydroxypropylmethylcellulose (HPMC). COOH-PS were used to mimic the size and the 
surface charge of HIV-1. Analysis of COOH-PS trajectories showed that particle mobility was decreased by Pluronic 
hydrogels in comparison with cynomolgus macaque cervicovaginal mucus and hydroxyethylcellulose hydrogel (HEC; 
1.5% by weight [wt%]) used as negative controls. Formulation of the peptide mini-CD4 M48U1 used as an anti-HIV-1 
molecule into a mixture of Pluronic F127 (20 wt%) and HPMC (1 wt%) did not affect its anti-HIV-1 activity in 
comparison with HEC hydrogel. The 50% inhibitory concentration (IC50) was 0.53 μg/ml (0.17 μM) for M48U1-HEC 
and 0.58 μg/ml (0.19 μM) for M48U1-F127-HPMC. The present work suggests that hydrogels composed of F127-
HPMC (20/1 wt%, respectively) can be used to create an efficient barrier against particle diffusion in comparison to 
conventional HEC hydrogels. 
 
INTRODUCTION 
According to the latest (2008) WHO and UNAIDS global estimates, among the 35 million people worldwide living 
with HIV, 50% are women. The first step in HIV infection by the vaginal route involves virus diffusion through vaginal 
mucus followed by the interaction of viral envelope proteins with their receptors on the surface of the vaginal host cells. 
Mucus is an entangled viscoelastic gel that coats the surfaces of the vaginal tract. It provides the outermost barrier 
against viral infections. The idea exposed in this work is to form a physical barrier composed of thermosensitive and 
mucoadhesive hydrogel against HIV diffusion, thus limiting virus attachment to mucosal surfaces of the vagina. The 
thermosensitive property of the (ethylene oxide)98(propylene oxide)67(ethylene oxide)98 (EO98PO67EO98) block 
copolymer designated Pluronic F127 or poloxamer P407 is particularly interesting for the design of vaginal 
microbicides acting as a physical barrier. At a certain concentration, this system is fluid at room temperature and in the 
form of a gel at body temperature (37°C) (1). In contrast to semisolid hydrogels, the administration of the formulation 
in the form of a solution (for instance, via syringes or another suitable device) facilitates its spreading on the mucosa, 
while the hydrogel layer on the mucosal surface could allow the formation of a physical barrier against virus diffusion. 
Mucoadhesion of Pluronic hydrogels was further improved by adding hydroxypropylmethylcellulose (HPMC) as a 
mucoadhesive polymer (1). 
Previous works reported different techniques for the investigation of this barrier effect by using viruses or virus-like 
particles. Diffusion chambers and Transwell-Snapwell chambers were used for hydrogel samples. The principle is based 
on donor-receptor duality. The sample containing the tracking substance, such as polystyrene particles, is placed in a 
donor chamber, and their passage in a receiver chamber filled with an appropriate liquid medium is observed (2, 3). 
However, this technique did not allow control of parameters such as thickness and uniformity of the sample layer, 
influence of preparation and handling on the structure of the sample, and optimal diameter of the pore to prevent 
blockage with the hydrogel sample (4). Fluorescence-labeled probe observations using fluorescence recovery after 
photobleaching (FRAP), single or multiple particle tracking (SPT or MPT, respectively), and fluorescence correlation 
spectroscopy (FCS) are other techniques that present the advantage of being “soft techniques” without effect on the 
structure of the sample (5). These methods demonstrated the utility of using fluorescence techniques to study the 
transport and the stability of particles in different media. Particularly, single or multiple particle tracking can give 
information at individual particle scale, while the fluorescence laser-equipped microscope (FRAP) method gives 
ensemble-average data. These techniques are based on FRAP or photo diodes (FCS) as a light source and acousto-optic 
filters or modulators. For SPT, a fast and sensitive camera is added to the system. This camera permits analysis of 
dynamic phenomena like particle movements in a medium by showing each particle as a dot. The size of the dot is 
related to the resolution of the objective. It is possible to calculate particle positions with subresolution precision using 
algorithms that can calculate the centers of the dots (6). 
The main objective of this work was to show that measuring the barrier effect of hydrogels is possible with soft 
techniques. We tried to correlate this barrier effect with Pluronic hydrogel intrinsic structure versus negative controls 
composed of macaque cervicovaginal mucus (CVM), hydroxyethylcellulose (HEC) hydrogel, and water. HEC hydrogel 
is very commonly used as a carrier of antiviral drugs in clinical studies on vaginal microbicides (7). Drug-free HEC 
hydrogel failed to prevent HIV transmission using macaque models (8, 9). 
In the present work, multiple particle tracking was used to quantify the mobility of 170-nm fluorescence-labeled and 
negatively charged COOH-modified polystyrene particles (COOH-PS) into Pluronic-based hydrogels. COOH-PS were 
used to mimic the size and the surface charge of HIV-1. The size of HIV-1 virions ranges from 120 to 180 nm, while 
mature HIV-1 ranges from 140 to 220 nm (10). COOH-PS are negatively charged, thus mimicking the anionic HIV-1 
virion envelope (4). Furthermore, multiple particle tracking showed that transport rates of COOH-PS are comparable to 
those of HIV in nonovulatory mucus (11). 
Finally, the anti-HIV-1 activity of the mini-CD4 M48U1 formulated into hydrogels was evaluated. This peptide was 
used as an HIV-1 molecule that targets the initial step of viral attachment to the CD4 cell receptor to block the viral 
entry (12–14). 
 
 
 
MATERIALS AND METHODS 
Ethical statement. Adult cynomolgus macaques (Macaca fascicularis) were imported from Mauritius and housed in 
the facilities of the Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA; Fontenay-aux-Roses, 
France). Nonhuman primates (NHP; including M. fascicularis) are used at the CEA in accordance with French national 
regulation and under national veterinary inspectors (CEA permit number A 92-032-02). The CEA is in compliance with 
Standards for Human Care and Use of Laboratory Animals of the Office for Laboratory Animal Welfare (OLAW, 
United States) under OLAW assurance number A5826-01. All experimental procedures were also conducted according 
to European guidelines for animal care (European directive 86/609, Journal Officiel des Communautée Européennes, 
L358, 18 December 1986). The use of NHP at CEA is also in accordance with recommendations in the newly published 
European Directive (2010/63, recommendation no. 9). No suffering was specifically associated with atraumatic vaginal 
fluid sampling in macaques. The animals were used under the supervision of the veterinarians in charge of the animal 
facility. 
 
M48U1 synthesis.The M48U1 peptide containing a p-(cyclohexylmethyloxy)phenylalanine residue at position 23 was 
synthesized at Pepscan Presto Inc. (Lelystad, The Netherlands) by solid-phase peptide synthesis and purified after 
refolding by reverse-phase high-performance liquid chromatography as described elsewhere (15). The M48U1 structure 
has been previously described (13). 
 
Preparation of hydrogels.HEC hydrogel (percentage by weight [wt%], 1.5) was prepared by adding 1.5 g of gelling 
polymer HEC (Natrosol 250 M Pharm; Aqualon, USA) to a vial containing citrate buffer (5 mM, pH 4.5). The volume 
was then brought up to 100 g with citrate buffer. The final formulation was mixed with a mechanical stirrer until 
complete dissolution of HEC. 
Pluronic-based hydrogels were prepared by weight according to the so-called cold method (1, 16, 17). 
For the preparation of Pluronic-based hydrogels (F127 20 wt% and F127-F68, 22.5/2.5 wt%, respectively), Pluronic 
powders (BASF, Ludwigshafen, Germany) were gradually added under magnetic agitation at 4°C to citrate buffer. The 
different preparations were designated by two numbers indicating the weight percentages of Pluronic F127 and Pluronic 
F68, respectively. 
For the preparation of formulations composed of F127-HPMC (20/x wt%) and F127-F68-HPMC (22.5/2.5/x wt%), 
HPMC powder (Methocel K4M series MM87091702 K; Colorcon) was gradually added under magnetic agitation at 
4°C to citrate buffer. The proportion of HPMC in the formulation designated x was varied as 0, 0.2, 0.5, 0.8, and 1 wt%. 
After complete dissolution of HPMC, Pluronic powders were gradually added to this phase under the same conditions 
of temperature and agitation. Preparations composed of F127-F68-HPMC were denominated by three numbers 
indicating the percentages by weight of F127, F68, and HPMC, respectively. 
Notably, F68 was added to modulate gelling temperature (Tgel), while HPMC was added to improve hydrogel 
mucoadhesion (1). 
M48U1 (3 mg/g) was formulated by adding the peptide to hydrogels. The hydrogels were homogenized by magnetic 
mixing (18). 
To investigate the effect of the pH on Tgel, the pH was adjusted to 7 using NaOH solution (Sigma-Aldrich, Saint-
Quentin Fallavier, France). 
In all cases, after complete dissolution of Pluronic powders, each formulation was hermetically sealed and stored for 48 
h at 4°C to eliminate foam and air bubbles. 
Rheological characterization of Pluronic-based hydrogels. All rheological measurements were carried out on a CSL 
100 controlled-stress rheometer (Carri-Med; Rhéo Champlan, France). The geometry was a stainless steel cone/plate 
(diameter, 40 mm; angle, 2°; and gap, 54 μm), which provided homogeneous shear of the sample. The cone was 
equipped with a solvent trap to limit evaporation during measurement. Thanks to Pelletier diodes placed in the lower 
plate, it was possible to perform temperature sweeps from 0 to 70°C with a precision of 0.1°C. Oscillatory (or dynamic) 
experiments were carried out. A sinusoidal shear was applied to the sample where the stress τ(t) and the strain γ(t) were 
defined as follows: (1) (2) 
τ0 and γ0 are, respectively, the maximal amplitudes of the stress and strain, ω is 2πN, N is the frequency, ω is the shear 
pulsation, and δ is the phase angle stress/strain. 
From the phase angle, one could define various dynamic viscoelastic quantities and especially the elastic (or storage) 
modulus G′ (equation 3) and the viscous (or loss) modulus G″ (equation 4). (3) (4) 
The higher the G′ value, the more pronounced the elastic character, and conversely, the higher the G″, the more 
pronounced the viscous properties. 
Hydrogel dynamic viscosities (η) were calculated from the viscous modulus G″ according to equation 5: (5) 
Viscosities were evaluated at two different temperatures: (i) at 17°C, before gelification, all the formulations are in the 
form of viscous liquid; (ii) at 37°C, after gelification, the formulations are in the form of highly viscous gel. 
The effect of HPMC addition on Tgel and η of Pluronic-based hydrogels was investigated after progressive addition of 
HPMC (0, 0.2, 0.5, 0.8, and 1 wt%) to hydrogels composed of F127 (20 wt%) and F127-F68 (22.5/2.5 wt%, 
respectively). 
All rheological results are the means of n = 3 experiments. 
 
Viscosity measurements of HEC hydrogel. Dynamic viscosity of HEC hydrogel was determined with an RS 600 
controlled-stress rheometer (19) (Haake; Rhéo, France) at 25°C and 37°C. The geometry used was the stainless steel 
cone/plate (35/0.5°; truncation, 29 μm), which provided homogenous shear of the samples and high values of the shear 
rate. 
 
Evaluation of hydrogel cytotoxicity. Evaluation of hydrogel cytotoxicity was first conducted on HeLa cells (from 
UMR-S 756 Inserm and Université Paris-Sud, Faculty of Pharmacy, Châtenay-Malabry, France). The cells were grown 
in Dulbecco's modified Eagle's minimum essential medium (DMEM) with L-glutamine supplemented with 10% heat-
inactivated fetal calf serum and 1% nonessential amino acids at 37°C in an atmosphere containing 5% CO2. Cell lines 
were harvested from the flask using trypsin (0.5 mg/ml) with EDTA (0.2 mg/ml), washed once with culture medium, 
and seeded into culture plates at the appropriate cell densities (150,000 cells/well) before being incubated for 24 h at 
37°C in an atmosphere containing 5% CO2. For maintenance, cells were passaged weekly using 0.02% trypsin in Ca
2+
-
Mg
2+
-free phosphate-buffered saline (PBS; 0.01 M, pH 7.4, at 25°C) containing 3 mM EDTA. The culture medium was 
changed every 2 days. Confluent HeLa cells were washed twice with PBS and then put in contact with hydrogels. The 
plates were incubated for 24 h at 37°C in a humidified atmosphere containing 5% CO2. At the end of the contact period, 
cells were washed twice with sterile PBS before analysis. Quantification of viable cells was conducted with trypan blue 
enumeration in a Malassez cell. 
Hydrogel cytotoxicity was also studied using the fully differentiated enterocyte-like Caco-2/TC7 clone cells (20, 21), 
and assays were performed on the mucin-secreting HT-29/MTX cell subpopulation (21, 22). 
Caco-2/TC7 cells (from UMR-S 756 Inserm and Université Paris-Sud, Faculty of Pharmacy, Châtenay-Malabry, 
France) were grown in DMEM with 25 mM glucose, supplemented with 15% heat-inactivated fetal calf serum and 1% 
nonessential amino acids. HT-29/MTX cells (from UMR-S 756 Inserm and Université Paris-Sud, Faculty of Pharmacy, 
Châtenay-Malabry, France) were grown in DMEM (25 mM glucose) supplemented with 10% heat-inactivated fetal 
bovine serum. For maintenance, cells (Caco-2/TC7 or HT-29/MTX) were passaged weekly using 0.02% trypsin in Ca
2+
-
Mg
2+
-free PBS containing 3 mM EDTA. 
Experiments and cell maintenance for Caco-2/TC7 and HT-29/MTX were carried out at 37°C in an atmosphere 
containing 10% CO2. The culture medium was changed daily. For Caco-2/TC7 cells, assays were performed with cells 
at passages between 15 and 32. Fully differentiated Caco-2/TC7 cells were obtained after 15 days in culture while HT-
29/MTX cultures were used at late postconfluence after 21 days in culture. Evaluation of hydrogel cytotoxicity was 
achieved after 24 h of direct contact with the cells. Cells were prepared in 24-well culture plates at 75,000 cells/well for 
Caco-2/TC7 cells and at 125,000 cells/well for HT-29/MTX cells. Before contact with hydrogels, confluent cells were 
washed twice with PBS. The plates were incubated for 24 h at 37°C in a humidified atmosphere containing 10% CO2. 
At the end of the contact period, cells were washed two times with sterile PBS before analysis. 
Whatever the cell line used, citrate buffer and simulated vaginal fluid (SVF) were used as controls. SVF was prepared 
by adding (under stirring) 900 ml of distilled water contained in a beaker, NaCl (3.51 g), KOH (1.4 g), Ca(OH)2 (0.22 
g), bovine serum albumin (0.018 g), lactic acid (2.00 g), acetic acid (1.00 g), glycerol (0.16 g), urea (0.40 g), and 
glucose (5.00 g). The stirring was maintained until complete dissolution. The pH of the mixture was then adjusted to 4.5 
using HCl, and the final volume was adjusted to 1 liter. All reagents for SVF preparation were from Sigma-Aldrich 
(Saint-Quentin Fallavier, France) and were of analytical grade. 
 
Video microscopy and multiple particle tracking. Particle transport rates were measured by analyzing the trajectories 
of fluorescence-labeled carboxylate-modified polystyrene particles (COOH-PS; 170-nm size; PS-Speck Microscope 
Point Source kit yellow-green fluorescent beads from Invitrogen, Molecular Probes, Eugene, Oregon, USA) in the 
hydrogels (F127-HPMC, 20/1 wt%, respectively; F127-F68-HPMC, 22.5/2.5/1 wt%, respectively; HEC, 1.5 wt%) and 
in macaque CVM. 
Macaque CVM was collected from 24 naive female cynomolgus macaques (Macaca fascicularis). The results were 
compared to the particle trajectories in water. Microscopic observations were made using an inverted AxioObserver Z1-
Colibri (Zeiss, Germany) video microscope equipped with a charge-coupled device (CCD) HSm camera (9.9-μm pixel 
size) under optimal incubation conditions provided by an XL incubator. Time-lapse images were acquired with a Plan-
Apochromat 63×/1.4-numerical-aperture (NA) oil-immersion objective lens, a 470-nm light-emitting diode (LED) for 
excitation, and a band-pass 505- to 550-nm filter to collect the emission of fluorescence. The data sets were processed 
using ImarisTrack 7.1.1 (Bitplane AG, Zurich, Switzerland) and Excel software. Experiments were carried out in 8-well 
glass chambers (Labtek, Campbell, CA), where 10 μl of 1/10-diluted particle solutions was added to 250 μl of Pluronic 
hydrogels, HEC hydrogel, macaque CVM, or water and incubated for 2 h at 37°C before microscopic observation. 
Trajectories of n = 10 particles were analyzed. Movies were captured with AxioVision 4.8 (Zeiss, Germany) software at 
a temporal resolution of 210 ms for 30 s. The coordinates of the particle centroid were transformed into time-averaged 
mean square displacements (MSDs) (equations 6 and 7) from which distributions of MSDs were calculated.
(6)where x1 = x (t1), x2 = x (t1 + τ), and τ is a fixed time lag.
(7) 
 
Evaluation of anti-HIV-1 activity of the formulations. HIV-1ada strain (NIBSC, London, United Kingdom) stocks 
were prepared (23) in the lymphoblastoid T CD4
+
 C8166 cell line (a kind gift from Stefano Butò, ISS, Rome, Italy). All 
viral stocks were titrated using an HIV-1 gag p24 antigen enzyme-linked immunosorbent assay (ELISA) kit 
(bioMérieux, Marcy l'Etoile, France) at 1,000 ng/ml of the HIV-1 gag p24 protein. The peripheral blood mononuclear 
cells (PBMCs) were separated from healthy donor peripheral blood using a Ficoll gradient (Ficoll-Histopaque; 
Pharmacia, Uppsala, Sweden) and seeded in RPMI 1640 (Gibco, Gaithersburg, MD, USA) plus 10% fetal calf serum 
(Gibco) and 2 mM L-glutamine (Gibco) medium at 5 × 10
5
 cells/ml. PBMCs were activated by phytohemagglutinin 
(PHA) (5 μg/ml; Sigma, St. Louis, MO, USA) plus interleukin-2 (IL-2) (10 U/ml; Pierce, Rockford, IL, USA) treatment 
for 72 h. The medium was replaced every 3 days with fresh medium. 
Scalar concentrations of M48U1-HEC or M48U1-F127-HPMC were preincubated with the HIV-1ada strain (5 ng/ml of 
HIV-1 gag p24) in RPMI 1640 for 1 h at 37°C or 4°C, respectively, and then added to PHA–IL-2-activated PBMCs that 
were adjusted to a final density of 1 × 10
6
 cells/ml for 2 h at 37°C. Final M48U1 concentrations were 0.1, 1, 3, and 10 
μg/ml. After four washes in PBS, cells were seeded at 1 × 106 PBMCs/ml into fresh medium represented by RPMI 1640 
plus 10% fetal calf serum and 2 mM L-glutamine with scalar dilutions of either M48U1-HEC or M48U1-F127-HPMC. 
As control, the same protocol of preincubation was applied on untreated cultures or samples treated by relative hydrogel 
dilutions without M48U1. To analyze HIV replication, HIV-1 gag p24 content was evaluated at day 7 postinfection in 
culture supernatants using an HIV-1 p24 antigen ELISA kit (bioMérieux, Marcy l'Etoile, France). The PBMC viability 
was evaluated by trypan blue exclusion at day 7 using the same scalar concentrations of M48U1-HEC or M48U1-F127-
HPMC indicated above. Untreated cell cultures were used as a control. 
 
RESULTS AND DISCUSSION 
Our strategy for the prevention of vaginal HIV transmission consists of the design of a barrier composed of Pluronic 
hydrogels containing the peptide mini-CD4 M48U1 able to better immobilize viral particles. This barrier could hinder 
HIV diffusion through mucus and its subsequent interaction with epithelial cells. Formulations composed of F127-
HPMC (20 wt%) and F127-F68-HPMC (22.5/2.5/1 wt%, respectively) exhibited thermosensitive properties, evaluated 
by measuring the variation of elastic and viscous moduli when the temperature is progressively increased (Fig. 1). Both 
formulations are fluid at room temperature, facilitating their application and spreading within the vaginal cavity, while 
they form a highly viscous hydrogel above sol-gel transition temperature, promoting prolonged contact time with the 
vaginal mucosa at body temperature. We have previously demonstrated that addition of HPMC improved mucoadhesion 
of Pluronic hydrogels (1). HPMC addition did not have an impact onTgel variation (Table 1). 
 
 
FIG 1. Typical profile of the variations of the elastic (G′, ●) and viscous (G″, ○) moduli, as a function of temperature. 
Experiments performed with hydrogels composed of F127-HPMC (20/1 wt%, respectively) (A) and F127-F68-HPMC 
(22.5/2.5/1 wt%, respectively) (B). 
 
TABLE 1 
Effect of HPMC proportion (x wt%) on Tgel and η of hydrogels composed of F127 (20 wt%) or F127-F68 (22.5/2.5 
wt%, respectively)a 
HPMC, xwt% 
F127-HPMC (20/x wt%, respectively) F127-F68-HPMC (22.5/2.5/x wt%, respectively) 
Tgel(°C) 
η (Pa/s) at: 
Tgel (°C) 
η (Pa/s) at: 
17°C 37°C 17°C 37°C 
0 22 ± 1 0.057 ± 0.001 101 ± 38 20 ± 1 0.259 ± 0.006 70 ± 22 
0.2 21 ± 1 0.078 ± 0.001 105 ± 43 20 ± 1 0.335 ± 0.002 100 ± 3 
0.5 21 ± 1 0.094 ± 0.002 108 ± 16 19 ± 1 0.453 ± 0.011 122 ± 48 
0.8 20 ± 1 0.129 ± 0.003 122 ± 4 18 ± 1 0.650 ± 0.028 206 ± 90 
1 21 ± 1 0.200 ± 0.015 172 ± 13 19 ± 1 0.710 ± 0.151 213 ± 15 
↵a N = 1 Hz. η was calculated from G″ according to the equation η =G″/2π. Data are the means of three determinations ± standard deviations. 
 
The pH of Pluronic hydrogels was 4.5, within the range of the normal, premenopausal vaginal pH. During coitus, 
vaginal secretions are temporarily neutralized by the alkaline pH of semen. Results in Table 2 showed that Tgel was not 
significantly modified when the pH increased from 4.5 to 7. 
TABLE 2 
Effect of pH on Tgel of hydrogels composed of F127-HPMC or F127-F68-HPMCa 
pH 
Tgel (°C) 
F127-HPMC (20/1 wt%, respectively) F127-F68-HPMC (22.5/2.5/1 wt%, respectively) 
4.5 21 ± 1 20 ± 1 
7 22 ± 1 21 ± 1 
 
 
  
 
In the present work, the ability of Pluronic hydrogels to decrease virus mobility was estimated by studying the 
trajectories of fluorescence-labeled carboxylate-modified polystyrene particles (COOH-PS; 170-nm size) using high-
resolution multiple particle tracking in comparison with their movements in HEC hydrogel, CVM, and water, used as 
negative controls. 
Particle mobility in water. The two-dimensional (2D) trajectories of COOH-PS in water exhibited a typical profile of 
the Brownian motion (Fig. 2, panel 1). The transport rates of different particle formulations in water were quantified by 
their time scale-dependent geometric ensemble-average mean square displacement (MSD) (Fig. 3). The slope α of each 
MSD curve was determined by fitting MSD to the equation MSD = 4 D0τ
α
, where D0 is the time scale-independent 
diffusion coefficient and τ is the time scale. α ranges from 0 for completely immobile particles to 1 for unobstructed 
Brownian diffusion, such as that of particles in water. Thus, a decrease of α value indicates increasing obstacles to 
particle movement. The slope of the MSD curves presented in Table 3 showed that α equals 1 as expected for pure 
unobstructed Brownian diffusion of particles in water. 
 
 
FIG 2 
(1) Typical trajectories of fluorescence-labeled COOH-modified polystyrene particles in water. (2) Typical trajectory of 
fluorescence-labeled COOH-modified polystyrene particles that are stationary in CVM. (3) Trajectory of the particles 
that are mobile in CVM. The trajectories were obtained at 37°C. 
 FIG 3 
Comparison of average mean square displacements (MSDs) as a function of time scale of COOH-PS in water (|), HEC 
(1.5 wt%) (×), and macaque CVM (◼) that are stationary in mucus, F127-HPMC (20/1 wt%, respectively) (★), and 
F127-F68-HPMC (22.5/2.5/1 wt%, respectively) (◆). The data were obtained at 37°C. 
TABLE 3 
Values of MSD, α, and Deff of COOH-PS in different mediab 
Sample MSD μm2at 1 s α Deff (μm
2/s) at 1 s Deff/Dw 
Water 1.09 1 0.26 1 
HEC (1.5 wt%) 0.07 56 × 10−3 0.017 0.065 
Macaque CVMa 1.66 × 10−4 0.070 × 10−3 3.95 × 10−5 15.19 × 10−5 
F127-F68-HPMC (22.5/2.5/1 wt%, respectively) 1.18 × 10−4 0.020 × 10−3 2.80 × 10−5 10.76 × 10−5 
F127-HPMC (20/1 wt%, respectively) 0.53 × 10−4 0.009 × 10−3 1.27 × 10−5 4.88 × 10−5 
↵a Data reported for particles stationary in mucus. 
↵b The slope α of each MSD curve was determined by fitting MSD to the equation MSD = 4 D0τα. 
 
Particle mobility in CVM.The analysis of COOH-PS trajectories in CVM showed that 54% of particles were strongly 
slowed in mucus in comparison with water (Fig. 2, panel 2), while 46% of particles were not immobilized by mucus and 
exhibited Brownian or near-Brownian trajectories (Fig. 2, panel 3).Mucus is mainly composed of water (95%) but also 
contains salts, lipids, enzymes, and proteins. The most important constituent of mucus is mucin. Mucin content usually 
ranges between 2 and 5% by weight. The immobilization of 54% of COOH-PS in mucus could be attributed to adhesive 
and low-affinity bonds of these particles with the hydrophobic domains of mucin. 
The mobility of 46% of particles could be due to the heterogeneous structure of mucus and their diffusion through the 
large pores of mucus. Mucus pore size is heterogeneous, varying from 20 to 3,000 nm depending on the technique used. 
It was evaluated at 650 ± 150 nm using the freeze-substitution fixation technique and transmission electron microscopy 
(24). Scanning and transmission electron microscopy after dimethyl sulfoxide-mediated glutaraldehyde fixation 
evaluated the mesh spacing between mucin fibers at 20 to 200 nm (25, 26). More recently, mucus pore size was 
estimated to 340 nm by multiple particle tracking (27). 
 
Particle trajectories in hydrogels.COOH-PS displacement was 16-fold lower in HEC than in water (Fig. 4, panels 2, 
and Table 3). The dynamic viscosity of HEC 1.5 wt% hydrogel determined at a shear rate of 0.1 s
−1
 was 3,200 mPa/s at 
25°C and 1,900 mPa/s at 37°C, which is much higher than the dynamic viscosity of water (1 mPa/s at 25°C and 0.6947 
mPa/s at 37°C) and could partly explain this reduced mobility. 
 
 FIG 4. (A) Examples of trajectories of fluorescence-labeled COOH-modified polystyrene particles in water (1), HEC 
(1.5 wt%) (2), F127-F68-HPMC (22.5/2.5/1 wt%, respectively) (3), and F127-HPMC (20/1 wt%, respectively) (4). A 
close-up of panels 2, 3, and 4 is presented in panel B. The trajectories were obtained at 37°C. 
 
Particles were strongly immobilized in both Pluronic hydrogels, F127-HPMC (20/1 wt%, respectively) and F127-F68-
HPMC (22.5/2.5/1 wt%, respectively). This was evidenced by the highly constrained, non-Brownian time-lapse traces 
of COOH-PS observed in Fig. 4 (panels 3 and 4). The results at a time scale of 1 s showed that MSD and the average 
diffusivity of particles were 1,320- and 590-fold lower in F127-HPMC and F127-F68-HPMC hydrogels than in HEC 
(Table 3). 
The higher dynamic viscosity of Pluronic hydrogels (Table 1) than of HEC hydrogel partly explains these differences. 
The two types of hydrogels are also different from a structural point of view. HEC is an ether of cellulose consisting of 
uncharged linear chains. Concerning Pluronic formulations, at low temperatures, before Tgel, copolymers exist in the 
form of unimers in low-viscosity aqueous solution. Upon heating, the dehydration of F127 unimers takes place and they 
begin to associate to form micelles composed of hydrophobic core formed by polypropylene oxide (PPO) blocks 
surrounded by the hydrophilic polyethylene oxide (PEO) blocks. When the temperature is increased above Tgel, Pluronic 
micelles arrange themselves in a well-organized crystalline structure. Small-angle X-ray diffraction experiments have 
shown that the diameter of each micelle was about 22 nm, and the distance between F127 20 wt% micelles was about 
21 nm at a temperature higher than Tgel (28). This organization results from lower mobility of COOH-PS into Pluronic-
based hydrogels than into HEC hydrogel. 
The two types of Pluronic hydrogels, F127-HPMC and F127-F68-HPMC, exhibited different behaviors regarding the 
mobility of COOH-PS. This mobility was 2-fold higher in the hydrogel composed of F127-F68-HPMC than in the 
hydrogel composed of F127-HPMC. This result was unexpected because hydrogel composed of Pluronic mixture F127-
F68-HPMC (22.5/2.5/1 wt%, respectively) was more viscous than hydrogel composed of F127-HPMC (20/1 wt%) at 
37°C (Table 1). These findings suggest that high viscosity of hydrogels is not the main parameter controlling particle 
mobility. In a previous work conducted by our research group, the effect of F68 on the molecular organization of F127 
micelles was studied (28). Micro-differential scanning calorimetry (micro-DSC) experiments unambiguously 
demonstrated that the two mixed Pluronic copolymers, F127 and F68, did not form mixed micelles but resulted in a 
segregation of the two kinds of copolymers (28). F68 is considered to be more hydrophilic than F127; its micellization 
temperature is higher. At 37°C, no micellization was detected at a concentration of F68 lower than 10 wt%. F127 
formulations are more stable and more homogenous, while the presence of F68 results in a disruption of the crystalline 
structure of F127 micelles. This disorganization due to F68 resulted in a higher mobility of COOH-PS shown inFig. 
3 and 4. 
These results clearly suggest that the relative efficiencies of hydrogels in hindering particle mobility are intimately 
related to their molecular structure. Hydrogel composed of F127 and HPMC is more suitable to be used as a physical 
barrier against HIV diffusion than the hydrogel composed of F127-F68 and HPMC. 
Cytotoxicity.The nontoxicity of the hydrogels was demonstrated in vitro using HeLa cells (Fig. 5). HeLa cells are 
nonoriented cells derived from a human cervical carcinoma. Experiments evaluating hydrogel cytotoxicity were also 
conducted using the fully differentiated Caco-2/TC7 clone cells and the mucus-secreting HT-29/MTX cell 
subpopulation. Although Caco-2/TC7 cells are not derived from vaginal tissues, they were used here as a model of 
differentiated cells forming monolayers of polarized cells while HT-29/MTX cells were used as a mucus-secreting cell 
model. HT-29/MTX cells produce mucus secreted by the specialized goblet cells that cover the apical cell surface (for a 
review, see reference 29). 
 
 FIG 5. Percentages of cell viability of HeLa (black bars), Caco-2/TC7 (gray bars), and HT29-MTX (hatched bars) cells 
after 24 h of contact with F127-HPMC (20/1 wt%, respectively) and F127-F68-HPMC (22.5/2.5/1 wt%, respectively) 
hydrogels, in comparison with HEC and SVF. The control was composed of 5 mM citrate buffer, pH 4.5. Data are the 
means of three determinations ± standard deviations. 
 
Whatever the cell model used, cell viability was found to be more than 80% for all samples. These results were in 
accordance with data from the literature on the toxicity of Pluronic hydrogels. Pluronic F127 has been approved by the 
FDA for use as a food additive and pharmaceutical ingredient. Moreover, Pluronic F127 hydrogel showed 
noncytotoxicity toward pig vaginal mucosa (30), indicating the biocompatibility of the Pluronic F127-based hydrogels 
reported here. 
 
Anti-HIV-1 activity of hydrogels containing M48U1.The antiviral effect of scalar concentrations of M48U1-F127-
HPMC was evaluated in comparison with M48U1-HEC (Table 4). The analysis of HIV-1 gag p24 content at day 7 
postinfection in cell supernatants by ELISA demonstrated that M48U1 formulated into HEC or F127-HPMC hydrogels 
(3 to 10 μg/ml, 1 to 3.3 μM) effectively inhibits HIV infection (Table 4). Here, the effect of hydrogel formulation of 
M48U1 antiviral activity is investigated for the first time. The viability of activated PBMCs treated with M48U1-HEC 
or M48U1-F127-HPMC scalar concentrations with antiretroviral effects was not significantly affected compared with 
the untreated cell cultures (Fig. 6). 
 
TABLE 4 
Antiviral activity of mini-CD4 M48U1 against HIV-1adainfectiona 
M48U1 concn, μg/ml (μM) 
HIV-1 gag p24 amt in medium: 
M48U1-HEC M48U1-F127-HPMC 
0 100 ± 10 100 ± 8 
0.1 (0.033) 85 ± 9 83 ± 9 
1 (0.33) 37 ± 6 42 ± 6 
3 (1) 4 ± 2 6 ± 2 
10 (3.3) 2 ± 1 3 ± 2 
IC50, μg/ml (μM) 0.53 (0.17 μM) 0.58 (0.19 μM) 
95% CI, μg/ml 0.2010–1.441 0.1765–1.923 
↵a HIV-1ada was preincubated for 1 h at 37°C or 4°C with scalar concentrations of M48U1-HEC or M48U1-F127-HPMC, respectively, in RPMI 1640 and challenged 
with activated PBMCs for 2 h at 37°C. HIV replication was monitored by HIV-1 gag p24 ELISA, and values were determined from cell culture supernatants at day 7 
postinfection. Data were expressed as the means ± standard deviations of HIV-1 gag p24 amount in relation to untreated control (set to 100%). Three experiments in 
duplicate were performed. IC50, 50% inhibitory concentration; CI, confidence interval. 
 
 FIG 6. Trypan blue analysis of activated PBMC viability treated by scalar concentrations of M48U1-HEC (black bars) 
and M48U1-F127-HPMC (gray bars) at day 7. M48U1-HEC and M48U1-F127-HPMC at M48U1 concentrations with 
antiretroviral activity are not toxic for PBMCs. Data were expressed as the means (± standard deviations) of viable cells 
relative to untreated controls (set to 100%) obtained from three independent experiments in duplicate. 
In conclusion, this investigation suggests that F127-HPMC (20/1 wt%, respectively) hydrogel could be suitable for use 
as a topical microbicide. Inclusion of an anti-HIV molecule in F127-HPMC (20/1 wt%, respectively) hydrogel 
represents an original strategy combining the effect of two barriers, mechanical and pharmacological, against HIV 
diffusion. 
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